Study Purpose: This study tests how well the medicine **batoclimab** works in people with **Thyroid Eye Disease (TED)**. It's a condition where the eyes become swollen and stick out more than usual. Participants will get batoclimab through an injection under the skin once a week for 24 weeks.
Key Terms:
- **Proptosis**: When the eye bulges out.
- **Placebo**: A dummy treatment that looks like the real medicine but has no active ingredients.
- **Euthyroid**: Having normal thyroid function.
Eligibility: You can join if you're 18 or older, have active and moderate to severe TED, and your condition started within the last year. You shouldn't need immediate eye surgery or therapy for TED during the study.
Key Points:
- Duration: The study lasts for 24 weeks with weekly treatment.
- Visits: Regular check-ups are needed to evaluate your condition.
- Risks: Prior use of certain steroids or having other autoimmune diseases may disqualify you.
How understandable was the trial content above?
Hard to understand
Easy to understand